A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the safety of single oral doses of 1592U89 (abacavir succinate, ABC) administered
to HIV-positive individuals. To determine the pharmacokinetics of 1592U89 after single oral
doses. To determine the effects of food on the bioavailability of 1592U89.